Percutaneous closure of patent ductus arteriosus

A multiinstitutional registry comparing multiple devices

Marissa A. Brunetti, Richard Ringel, Carl Owada, John Coulson, Jacky M. Jennings, Mark Hoyer, Allen D. Everett

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background: There are no guidelines and multiple devices available now for closure of PDA. Objective: We sought to determine which devices are used and their outcomes. Methods: Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008. Results: PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 ± 6.8 years, 18.7 ± 18.4 kg, and 2.1 ± 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 ± 7.5 min, P = 0.00001, 2.6 ± 1.4 cm3 kg-1, P = 0.00001). Immediate angiographic success rates were 96.9% (156/161) for Gianturco coils, 89.7% (156/174) for the ADO, 100% (18/18) for Flipper coils, and 66.7% (4/6) for other devices. Major complication rates were 0.6% for Gianturco coils (1/161), 1.7% for ADO (3/174), and 83.3% for other devices (4/6). Minor complication rates by device were 1.9% for Gianturco coils (3/161), 2.3% for ADO (4/174), and 16.7% (1/6) for other devices. Conclusions: Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure.

Original languageEnglish
Pages (from-to)696-702
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Volume76
Issue number5
DOIs
StatePublished - Nov 1 2010

Fingerprint

Patent Ductus Arteriosus
Registries
Equipment and Supplies
Septal Occluder Device
beta-apocarotenoid-14',13'-dioxygenase
Fluoroscopy
Catheterization
Guidelines
Radiation
Weights and Measures
Costs and Cost Analysis

Keywords

  • cardiovascular abnormalities
  • congenital heart defects
  • heart catheterization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Percutaneous closure of patent ductus arteriosus : A multiinstitutional registry comparing multiple devices. / Brunetti, Marissa A.; Ringel, Richard; Owada, Carl; Coulson, John; Jennings, Jacky M.; Hoyer, Mark; Everett, Allen D.

In: Catheterization and Cardiovascular Interventions, Vol. 76, No. 5, 01.11.2010, p. 696-702.

Research output: Contribution to journalArticle

Brunetti, Marissa A. ; Ringel, Richard ; Owada, Carl ; Coulson, John ; Jennings, Jacky M. ; Hoyer, Mark ; Everett, Allen D. / Percutaneous closure of patent ductus arteriosus : A multiinstitutional registry comparing multiple devices. In: Catheterization and Cardiovascular Interventions. 2010 ; Vol. 76, No. 5. pp. 696-702.
@article{ed6b96fda593415a863a9a3359811f81,
title = "Percutaneous closure of patent ductus arteriosus: A multiinstitutional registry comparing multiple devices",
abstract = "Background: There are no guidelines and multiple devices available now for closure of PDA. Objective: We sought to determine which devices are used and their outcomes. Methods: Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008. Results: PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 ± 6.8 years, 18.7 ± 18.4 kg, and 2.1 ± 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 ± 7.5 min, P = 0.00001, 2.6 ± 1.4 cm3 kg-1, P = 0.00001). Immediate angiographic success rates were 96.9{\%} (156/161) for Gianturco coils, 89.7{\%} (156/174) for the ADO, 100{\%} (18/18) for Flipper coils, and 66.7{\%} (4/6) for other devices. Major complication rates were 0.6{\%} for Gianturco coils (1/161), 1.7{\%} for ADO (3/174), and 83.3{\%} for other devices (4/6). Minor complication rates by device were 1.9{\%} for Gianturco coils (3/161), 2.3{\%} for ADO (4/174), and 16.7{\%} (1/6) for other devices. Conclusions: Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure.",
keywords = "cardiovascular abnormalities, congenital heart defects, heart catheterization",
author = "Brunetti, {Marissa A.} and Richard Ringel and Carl Owada and John Coulson and Jennings, {Jacky M.} and Mark Hoyer and Everett, {Allen D.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1002/ccd.22538",
language = "English",
volume = "76",
pages = "696--702",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Percutaneous closure of patent ductus arteriosus

T2 - A multiinstitutional registry comparing multiple devices

AU - Brunetti, Marissa A.

AU - Ringel, Richard

AU - Owada, Carl

AU - Coulson, John

AU - Jennings, Jacky M.

AU - Hoyer, Mark

AU - Everett, Allen D.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Background: There are no guidelines and multiple devices available now for closure of PDA. Objective: We sought to determine which devices are used and their outcomes. Methods: Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008. Results: PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 ± 6.8 years, 18.7 ± 18.4 kg, and 2.1 ± 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 ± 7.5 min, P = 0.00001, 2.6 ± 1.4 cm3 kg-1, P = 0.00001). Immediate angiographic success rates were 96.9% (156/161) for Gianturco coils, 89.7% (156/174) for the ADO, 100% (18/18) for Flipper coils, and 66.7% (4/6) for other devices. Major complication rates were 0.6% for Gianturco coils (1/161), 1.7% for ADO (3/174), and 83.3% for other devices (4/6). Minor complication rates by device were 1.9% for Gianturco coils (3/161), 2.3% for ADO (4/174), and 16.7% (1/6) for other devices. Conclusions: Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure.

AB - Background: There are no guidelines and multiple devices available now for closure of PDA. Objective: We sought to determine which devices are used and their outcomes. Methods: Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008. Results: PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 ± 6.8 years, 18.7 ± 18.4 kg, and 2.1 ± 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 ± 7.5 min, P = 0.00001, 2.6 ± 1.4 cm3 kg-1, P = 0.00001). Immediate angiographic success rates were 96.9% (156/161) for Gianturco coils, 89.7% (156/174) for the ADO, 100% (18/18) for Flipper coils, and 66.7% (4/6) for other devices. Major complication rates were 0.6% for Gianturco coils (1/161), 1.7% for ADO (3/174), and 83.3% for other devices (4/6). Minor complication rates by device were 1.9% for Gianturco coils (3/161), 2.3% for ADO (4/174), and 16.7% (1/6) for other devices. Conclusions: Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure.

KW - cardiovascular abnormalities

KW - congenital heart defects

KW - heart catheterization

UR - http://www.scopus.com/inward/record.url?scp=78349232440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349232440&partnerID=8YFLogxK

U2 - 10.1002/ccd.22538

DO - 10.1002/ccd.22538

M3 - Article

VL - 76

SP - 696

EP - 702

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 5

ER -